A7502
DL-Alanine
≥99% (HPLC)
Synonym(s):
(±)-2-Aminopropionic acid
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Linear Formula:
CH3CH(NH2)COOH
CAS Number:
Molecular Weight:
89.09
UNSPSC Code:
12352209
NACRES:
NA.26
PubChem Substance ID:
EC Number:
206-126-4
Beilstein/REAXYS Number:
1720250
MDL number:
InChI key
QNAYBMKLOCPYGJ-UHFFFAOYSA-N
InChI
1S/C3H7NO2/c1-2(4)3(5)6/h2H,4H2,1H3,(H,5,6)
SMILES string
CC(N)C(O)=O
assay
≥99% (HPLC)
form
powder
technique(s)
ligand binding assay: suitable
color
white to off-white
mp
289 °C (dec.) (lit.)
solubility
H2O: soluble
application(s)
peptide synthesis
Quality Level
Looking for similar products? Visit Product Comparison Guide
Application
DL-Alanine, a racemic mixture of D- and L-alanine, is used as a model reagent for development of amino acid racemic resolution techniques. DL-Alanine is used in mixed ligand (chelate) studies with transition metals such as Cu(II), Zn(ll) and Cd(ll).
Storage Class
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Tatjana Braun et al.
Proceedings of the National Academy of Sciences of the United States of America, 112(30), 9340-9345 (2015-07-01)
The prokaryotic origins of the actin cytoskeleton have been firmly established, but it has become clear that the bacterial actins form a wide variety of different filaments, different both from each other and from eukaryotic F-actin. We have used electron
Janine Rohrbach et al.
Antiviral therapy, 19(2), 149-159 (2013-09-17)
We investigated changes in biomarkers of liver disease in HIV-HCV-coinfected individuals during successful combination antiretroviral therapy (cART) compared to changes in biomarker levels during untreated HIV infection and to HIV-monoinfected individuals. Non-invasive biomarkers of liver disease (hyaluronic acid [HYA], aspartate
Andrea Schlegel et al.
Annals of surgery, 260(5), 839-846 (2014-11-08)
To develop a reproducible animal model mimicking a novel 2-staged hepatectomy (ALPPS: Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy) and explore the underlying mechanisms. ALPPS combines portal vein ligation (PVL) with liver transection (step I), followed by
Safiah H C Mai et al.
Shock (Augusta, Ga.), 44(2), 166-172 (2015-05-27)
Sepsis is characterized by systemic activation of coagulation and inflammation in response to microbial infection. Although cell-free DNA (cfDNA) released from activated neutrophils has antimicrobial properties, it may also exert harmful effects by activating coagulation and inflammation. The authors aimed
Paola Maffi et al.
Transplantation, 98(12), 1301-1309 (2014-10-07)
Our final objective is to develop an adoptive therapy with tolerogenic donor-specific type 1 T regulatory cells for patients with type 1 diabetes undergoing islet transplantation. The achievement of this objective depends on the availability of an immunosuppressive treatment compatible
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service